Close

Medical Research Council Finds Antibody Capable of Fighting Flu

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Related stories

Regulatory Strategy for Early-Stage Biotech and Medtech Companies

Early-stage companies tend to focus on the science and...

BioNTech and Gilead Partner for Pumitamig Clinical Trial

BioNTech SE has officially entered into a clinical trial...
- Advertisement -

An antibody that can fight all types of the influenza A virus has been identified by researchers from the Medical Research Council’s National Institute for Medical Research.

Studies in fly-infected mice showed that the antibody could be used as an emergency treatment or in the development of a universal vaccine, rather than be used to create a new vaccine each winter. The antibody, named FI6, targets a protein found on the surface of the virus, called haemagglutinin. Mice infected with a lethal dose of the H1N1 virus were injected with the antibody two days after the virus was recorded and survived.

 

Never miss a pharmaceutical headline

The pharmaceutical industry moves fast – stay on top of it with our must - read briefings.

  • The top pharma and life sciences stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments driving the global pharmaceutical sector

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Latest stories

Related stories

Regulatory Strategy for Early-Stage Biotech and Medtech Companies

Early-stage companies tend to focus on the science and...

BioNTech and Gilead Partner for Pumitamig Clinical Trial

BioNTech SE has officially entered into a clinical trial...

Cencora to Acquire American Oncology Network in $2.4 Billion Deal

Cencora has signed a definitive agreement to acquire American...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Translate »